Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson’s disease

被引:0
作者
Zhanyun Lv
Hong Jiang
Huamin Xu
Ning Song
Junxia Xie
机构
[1] Medical College of Qingdao University,Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders
[2] Medical College of Qingdao University,Department of Physiology, State Key Disciplines: Physiology in Incubation
来源
Journal of Neural Transmission | 2011年 / 118卷
关键词
Divalent metal transporter 1; Ferroportin 1; Iron; Α-synuclein; Parkinson’s disease;
D O I
暂无
中图分类号
学科分类号
摘要
The staging of Lewy-related pathology in sporadic Parkinson’s disease (PD) reveals that many brain nuclei are affected in PD during different stages, except the ventral tegmental area (VTA), which is close related to the substantia nigra (SN) and enriched in dopamine (DA) neurons. Why DA neurons are selectively degenerated in the SN of PD is far from known. In the present study, we observed that the number of tyrosine hydroxylase immunoreactive neurons decreased and iron-staining positive cells increased in the SN, but not in the VTA, in the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated PD mice. Increased expression of divalent metal transporter 1 and decreased expression of ferroportin 1 might associate with this increased nigral iron levels. Lipofuscin granular aggregations and upregulation of alpha-synuclein (α-synuclein) were also observed only in the SN. These results suggest that increased iron levels associate with the selective degeneration of DA neurons in the SN. The intracellular regulation mechanisms for the iron transporters may be different in the SN and VTA under the same conditions. Moreover, the lipofuscin granular aggregations and upregulation of α-synuclein were also involved in the selective degeneration of dopaminergic neurons in the SN.
引用
收藏
页码:361 / 369
页数:8
相关论文
共 216 条
  • [1] Bartzokis G(1999)MRI evaluation of brain iron in earlier- and later-onset Parkinson’s disease and normal subjects Magn Reson Imaging 17 213-222
  • [2] Cummings JL(1995)Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography Neurology 45 182-184
  • [3] Markham CH(2001)Echo pattern of substantia nigra and its relevance for motor function and motility in elderly subjects Neurology 56 13-17
  • [4] Marmarelis PZ(2008)Invited Article: nervous system pathology in sporadic Parkinson disease Neurology 70 1916-1925
  • [5] Treciokas TA(2001)Alpha-synuclein immunopositive Parkinson’s disease-related inclusion bodies in lower brain stem nuclei Acta Neuropathol 101 195-201
  • [6] Tishler TA(2004)Stages in the development of Parkinson’s disease-related pathology Cell Tissue Res 318 121-134
  • [7] Marder SR(2005)Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments J Biol Chem 280 9678-9690
  • [8] Mintz J(1998)Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease Nat Med 4 1318-1320
  • [9] Becker G(2000)Accelerated oligomerization by Parkinson’s disease linked alpha-synuclein mutants Ann N Y Acad Sci 920 42-45
  • [10] Seufert J(1999)The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease Brain 122 1437-1448